Starrkirch, Switzerland

Kurt Steiner

This inventor holds 3 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1976-1997.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 45(Granted Patents)


Location History:

  • Starrkirch, CH (1976 - 1995)
  • Starrkirch-Wil, CH (1997)

Company Filing History:


Years Active: 1976-1997

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kurt Steiner: Innovator in Chemical Processes

Introduction

Kurt Steiner is a notable inventor based in Starrkirch, Switzerland. He has made significant contributions to the field of chemistry, particularly in the development of innovative processes for the manufacture of complex chemical compounds. With a total of 3 patents to his name, Steiner's work has implications in various industries, including pharmaceuticals.

Latest Patents

Steiner's latest patents include a process for the manufacture of 4H-imidazo[1,5-a]benzodiazepines. This process focuses on creating derivatives of a specific formula, where R¹ can be phenyl or mono- or disubstituted phenyl. Another significant patent involves the method for the production of β-ionone from pseudoionone. This process utilizes a sulfuric acid-catalyzed cyclization in a two-phase solvent system, which is crucial for synthesizing vitamin A.

Career Highlights

Kurt Steiner is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at the company has allowed him to explore and develop innovative chemical processes that enhance production efficiency and product quality.

Collaborations

Steiner has collaborated with esteemed colleagues such as Karl-Heinz Bender and Manfred W. Breuninger. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their respective fields.

Conclusion

Kurt Steiner's contributions to chemical processes exemplify the spirit of innovation in the scientific community. His patents and collaborations reflect a commitment to advancing technology and improving manufacturing methods in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…